We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05465954
Brief Title: Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

First Submitted : July 18, 2022
First Submitted that Met QC Criteria : July 18, 2022
First Posted : July 20, 2022

Last Update Submitted that Met QC Criteria : February 1, 2023
Last Update Posted : February 2, 2023